IL1B and familial Mediterranean fever: Targeted treatments have been used in several systemic autoimmune/inflammatory diseases, including (but not limited to) IL‐1 blocking strategies in cryopyrin‐associated periodic syndromes and otherwise treatment‐refractory FMF.140, 141